Literature DB >> 2542004

Second messenger signaling in the regulation of collagenase production by osteogenic sarcoma cells.

R Civitelli1, K A Hruska, J J Jeffrey, A J Kahn, L V Avioli, N C Partridge.   

Abstract

Recent work indicates that PTH can stimulate osteoblastic cells to secrete neutral collagenase, an enzyme thought to be linked to bone matrix turnover. Since recent studies suggest that the calcium/protein kinase-C (PKC) message system is involved in signal transduction stimulated by PTH, we examined the role of these putative second messengers of PTH in the regulation of collagenase production by the osteoblastic tumor cell line UMR 106-01. Immunohistochemical staining of cells exposed to PTH (10(-7) M) revealed that about 20% of the entire population was positive for collagenase, compared to less than 3% staining positively in control untreated cells. Incubation with the cAMP analog 8-bromo-cAMP (8BrcAMP) increased the number of collagenase-staining cells in a dose-dependent manner (ED0.5 = 2.5 x 10(-4) M), but to a lower level than PTH, with the maximal effect producing about 15% positive cells. The calcium ionophore ionomycin (10(-7) M) was ineffective, whereas phorbol 12-myristate 13-acetate (PMA), a PKC activator, increased collagenase-specific staining to about 5%, but only at high concentrations (10(-5) M). Incubation of UMR 106-01 cells with ionomycin and PMA did not change the effect of the latter. When the three agents were used in combination, an additive effect was observed, which fully reproduced that of PTH. Similarly, the amount of collagenase released into the medium by cells stimulated with maximal concentrations of 8BrcAMP (10(-3) M) was only 80% of that induced by maximal doses of PTH (10(-7) M). PMA (10(-5) M) was slightly stimulatory, and ionomycin was ineffective alone, but they were synergistic with submaximal doses of 8BrcAMP (10(-4) M). In agreement with the immunohistochemical results, the full hormonal effect was reproduced when the three second messenger analogs were used in combination. In conclusion, signal transduction from PTH receptor to collagenase production is mediated mainly by cAMP; the Ca2+/PKC system appears to have a contributory role necessary for the full expression of hormonal response. These results support the hypothesis of a dual pathway of target cell activation by PTH.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2542004     DOI: 10.1210/endo-124-6-2928

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  Specific down-regulation of parathyroid hormone (PTH) receptors and responses to PTH by tumour necrosis factor alpha and retinoic acid in UMR 106-06 osteoblast-like osteosarcoma cells.

Authors:  H G Schneider; E H Allan; J M Moseley; T J Martin; D M Findlay
Journal:  Biochem J       Date:  1991-12-01       Impact factor: 3.857

2.  Teriparatide increases the maturation of circulating osteoblast precursors.

Authors:  P D'Amelio; C Tamone; F Sassi; L D'Amico; I Roato; S Patanè; M Ravazzoli; L Veneziano; R Ferracini; G P Pescarmona; G C Isaia
Journal:  Osteoporos Int       Date:  2011-05-27       Impact factor: 4.507

Review 3.  Systemic and local factors and the maintenance of bone quality.

Authors:  E Canalis
Journal:  Calcif Tissue Int       Date:  1993       Impact factor: 4.333

4.  Influence of phase I periodontal therapy on levels of matrix metalloproteinase 1 and tissue inhibitor of metalloproteinase 1.

Authors:  Pallavi S Ghodpage; Rajashri A Kolte; Abhay P Kolte; Madhur Gupta
Journal:  Saudi Dent J       Date:  2014-07-15

5.  Regulation of ornithine decarboxylase by parathyroid hormone in osteoblastic cell systems.

Authors:  S L Cheng; A Fausto; O A Jänne; L V Avioli
Journal:  Calcif Tissue Int       Date:  1992-11       Impact factor: 4.333

6.  Opposite and independent actions of cyclic AMP and transforming growth factor beta in the regulation of type 1 plasminogen activator inhibitor expression.

Authors:  F W Thalacker; M Nilsen-Hamilton
Journal:  Biochem J       Date:  1992-11-01       Impact factor: 3.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.